Label Changes for:

Allegra-D 24 hour (fexofenadine HCL 180mg/pseudoephedrinie HCL 240mg) extended release tablets

April 2010

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2010

ADVERSE REACTIONS

Pseudoephedrine Hydrochloride
  • ischemic colitis have been reported
Hide
(web4)